Peter Ulrichts, PhDResearch Fellow, Lead Scientist at Argen-X N.V.Speaker
Profile
Peter obtained a PhD in immunology from the university of Ghent (Belgium). After a short post-doc period, he joined argenx in 2010 as research scientist where he was involved in the development of various therapeutic antibodies for the treatment of cancer and autoimmune diseases. In 2013, he headed the development of argenx’ FcRn antagonist ARGX-113 until the first-in-human study. Currently, he is the lead scientist of the ARGX-113 program.